• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR MITRACLIP XTR CLIP DELIVERY SYSTEM; VALVE REPAIR

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR MITRACLIP XTR CLIP DELIVERY SYSTEM; VALVE REPAIR Back to Search Results
Catalog Number UNK CDS06
Device Problems Off-Label Use (1494); Incomplete Coaptation (2507)
Patient Problem Tricuspid Regurgitation (2112)
Event Date 09/01/2017
Event Type  Injury  
Manufacturer Narrative
The udi is unknown because the part number and lot number were not provided.The device was not returned for analysis and a review of the lot history record could not be performed as the part and lot information regarding the complaint device was not provided.Based on the available information, a cause for the reported single leaflet device attachment/slda could not be determined.A cause for the reported patient effect of recurrent tricuspid regurgitation (tr) could not be determined.The reported patient effect of recurrent tr is listed in the mitraclip system instructions for use (ifu), and is a known possible complication associated with mitraclip procedures.The reported additional therapy/non-surgical treatment was a result of case-specific circumstances.It should also be noted that the mitraclip ifu states: ¿do not use mitraclip outside of the labeled indication¿.Since mitraclip was used for a tricuspid valve procedure, this is considered as an off-label use of the device.However, it could not be determined if using the mitraclip on the tricuspid valve caused or contributed to the reported events.There is no indication of a product quality issue with respect to manufacture, design or labeling.Article titled, "comparison of transcatheter tricuspid valve repair using the mitraclip ntr and xtr systems.".
 
Event Description
This is filed to report recurrent tricuspid regurgitation, single leaflet device attachment/ slda), medical intervention.It was reported in an article review that this was a mitraclip procedure to treat tricuspid regurgitation (tr).An xtr clip delivery system (cds) was advanced to the tricuspid valve for off label use, and the clip was deployed.However, the clip became detached from one leaflet, but remained attached to the other leaflet (single leaflet device attachment/ slda).A 30-day follow up revealed that the patient had recurrent tr which was treated through medical management.No additional information was provided.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
MITRACLIP XTR CLIP DELIVERY SYSTEM
Type of Device
VALVE REPAIR
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005070406
3885 bohannon drive
menlo park CA 94025
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key11132708
MDR Text Key225575058
Report Number2024168-2021-00222
Device Sequence Number1
Product Code NKM
Combination Product (y/n)N
Reporter Country CodeCA
PMA/PMN Number
P100009
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type literature
Reporter Occupation Physician
Type of Report Initial
Report Date 01/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Catalogue NumberUNK CDS06
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 12/15/2020
Initial Date FDA Received01/07/2021
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
-
-